SEC Form D · filed November 21, 2018
Oncternal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Richard B. Vincent · San Diego, CAExecLauren G. Otsuki · San Diego, CAExecJames B. Breitmeyer, M.D., Ph.D · San Diego, CAExec · DirectorDavid F. Hale · San Diego, CADirectorScott L. Glenn · San Diego, CADirectorWilliam R. Larue · San Diego, CADirectorCam B. Gallagher · San Diego, CADirectorCooper R. Collins · San Diego, CADirectorGarheng P. Kong · New Haven, CTDirectorPaul T. Estrem · New Haven, CTExec · DirectorOlivier Ries · Luxembourg, LuxembourgDirectorMichael A. Moceri · Chicago, ILDirectorKaren J. Jakobi · Irvine, CAExecCarolin Steinmann · Pfaffikon, V8DirectorStan Johnson · Fargo, NDDirectorThomas A. Roszak · Northfield, ILExecCharles G. Theuer, M.D · San Diego, CADirectorSteven Kay · San Francisco, CAExecMark Jorgensen · San Francisco, CADirectorAllen R. Page · Waxahachie, TXDirectorGayle Troberman · New York, NYDirectorDavid J. Winograd · Milwaukee, WIExec · DirectorDamian Caldwell · Winston-Salem, NCExecRichard Simoni · Palo Alto, CADirectorDavid Fleshman · Palo Alto, CADirectorCharles G. Theuer, M.D · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗